🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

211 results for “Jian” Clear

  1. 610 30mg group

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Asthma

    phase 1 small molecule active

    1 trial

  2. 626

    Jian Li

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  3. 626

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  4. 627

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 mab active

    1 trial

  5. 68Ga-FAPI-04

    Jian Li

    Fibrosis

    phase 1 small molecule active

    1 trial

  6. APL-1202 and APL-1501 (Single ascending dose)

    Jian Li

    Bladder Cancer

    phase 1 small molecule active

    1 trial

  7. Ad5-EBOV

    Jian Li

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  8. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule terminated

    1 trial

  9. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  10. Clascoterone Cream 1%

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acne Vulgaris

    phase 1 small molecule completed

    1 trial

  11. Clifutinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Subject

    phase 1 small molecule active

    1 trial

  12. Clifutinib Besylate

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  13. Clifutinib with fed state

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia in Children

    phase 1 small molecule completed

    1 trial

  14. Daridorexant

    Jian Li

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  15. Drug 601

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Wet Age-related Macular Degeneration

    phase 1 small molecule active

    1 trial

  16. Drug 601

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Macular Edema

    phase 1 small molecule active

    1 trial

  17. Freethiadine tablets(part I)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  18. GST-HG121 tablets

    Jian Li

    Pharmacokinetics

    phase 1 small molecule active

    1 trial

  19. HBT-708

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  20. HEC 68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  21. HEC-007 injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects

    phase 1 small molecule active

    1 trial

  22. HEC-151 Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  23. HEC113995

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  24. HEC113995 PA•H2O tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources